S-Adenosyl-L-methionine 1,4-butanedisulfonate
Based on 18 publication(s) in Google Scholar
S-Adenosyl-L-methionine (S-Adenosyl methionine) 1,4-butanedisulfonate is an orally active methyl group donor. S-Adenosyl-L-methionine 1,4-butanedisulfonate is a dietary supplement with potent antidepressant effects. S-Adenosyl-L-methionine 1,4-butanedisulfonate also has anti‑proliferative, pro‑apoptotic and anti‑metastatic roles in cancers. S-Adenosyl-L-methionine 1,4-butanedisulfonate has the potential for, cancer, liver disease and osteoarthritis research.
For research use only. We do not sell to patients.
- CAS No.: 200393-05-1
- Formula: C19H32N6O11S3
- Molecular Weight:616.69
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) S-Adenosyl-L-methionine 1,4-butanedisulfonate
More- Mol Cancer. 2025 Nov 20;24(1):295. [Abstract]
- Nat Commun. 2024 Nov 12;15(1):9529. [Abstract]
- Gut Microbes. 2025 Dec;17(1):2545434. [Abstract]
- Environ Sci Technol. 2025 Jan 14;59(1):268-278. [Abstract]
- J Exp Med. 2026 Jan 5;223(1):e20250603. [Abstract]
- J Agric Food Chem. 2021 Aug 11;69(31):8737-8746. [Abstract]
- Biochem Pharmacol. 2024 Jan:219:115967. [Abstract]
- Ind Crops Prod. 2025 Dec 2;238:122414.
- Plant J. 2025 Apr;122(2):e70182. [Abstract]
- Int Immunopharmacol. 2021 Jun:95:107545. [Abstract]
- Epigenetics Chromatin. 2021 Dec 4;14(1):52. [Abstract]
- J Pharm Biomed Anal. 2024 Apr 15:241:115991. [Abstract]
- SSRN. 2026 Jun 23.
- Biomed Pharmacother. 2025 Aug:189:118246. [Abstract]
- bioRxiv. 2025 Jun 27.
- bioRxiv. 2023 Jun 1.
- Research Square Preprint. 2021 Jun.
- Research Square Preprint. 2020 Aug.
-
WB
All Endogenous Metabolite Isoforms
More
Biological Activity
Description
In Vitro
S-Adenosyl-L-methionine (300 µM, 24 or 48 h) 1,4-butanedisulfonate induces cell apoptosis, and promotes the cell cycle arrest in Cal-33 and JHU-SCC-011 cells[4].
S-Adenosyl-L-methionine (300 µM, 24 h) 1,4-butanedisulfonate decreases the migration of the Cal-33 and JHU-SCC-011 cells[4].
S-Adenosyl-L-methionine (5-40 μg/mL, 48 h) 1,4-butanedisulfonate protects the anticancer effect of 5‑FU by regulating the expression of DNMTs[5].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:Cal-33 and JHU-SCC-011 cells
-
Concentration:300 µM
-
Incubation Time:24 h (Cal-33) or 48 h (HU-SCC-011)
-
Result:Showed an approximately 10% and 3%of apoptotic cells respectively.
-
Cell Line:Cal-33 and JHU-SCC-011 cells
-
Concentration:300 µM
-
Incubation Time:24 h (Cal-33) or 48 h (HU-SCC-011)
-
Result:Decreased the expression of cyclin B1, E1 and D1 in the Cal-33 and JHU-SCC-011 cells.
In Vivo
S-Adenosyl-L-methionine (50 and 100 mg/kg, p.o.) 1,4-butanedisulfonate shows antiepileptic, memory-enhancing, and antioxidant properties in a Pentylenetetrazole-induced rat epilepsy model[7].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Valproic acid treated young mice[6]
-
Dosage:30 mg/kg
-
Administration:p.o., for 3 days
-
Result:Alleviated most ASD like neurobehavioral symptoms.
Normalized the redox potential in the prefrontal cortex.
Chemical Information
-
CAS No. 200393-05-1
-
Molecular Weight 616.69
-
Formula C19H32N6O11S3
-
SMILES
O=S(CCCCS(=O)(O)=O)(O)=O.O[C@H]1[C@@H](O[C@@H]([C@H]1O)C[S+](C)CC[C@H](N)C([O-])=O)N2C3=NC=NC(N)=C3N=C2
-
Synonyms
S-Adenosyl methionine 1,4-butanedisulfonate; Ademetionine 1,4-butanedisulfonate; AdoMet 1,4-butanedisulfonate
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (18)
-
Journal Impact Factor
-
Most Recent
-
Mol Cancer
ZNF526 drives tumor growth by enhancing SHMT1-dependent serine metabolism and antioxidant capability in TNBC. [Abstract]2025 Nov 20;24(1):295. PMID: 41267037 -
Nat Commun
2024 Nov 12;15(1):9529. PMID: 39532843 -
Gut Microbes
Gut microbiota-mediated betaine regulates skeletal muscle fiber type transition by affecting m6A RNA methylation and Myh7 expression. [Abstract]2025 Dec;17(1):2545434. PMID: 40824213 -
Environ Sci Technol
Arsenic Exposure Triggers Nonalcoholic Fatty Liver Disease through Repressing S-Adenosylmethionine-Dependent Histone Methylation in Rats. [Abstract]2025 Jan 14;59(1):268-278. PMID: 39746780 -
J Exp Med
Adenosine metabolic clearance maintains liver homeostasis by licensing arginine methylation of RIPK1. [Abstract]2026 Jan 5;223(1):e20250603. PMID: 41081715 -
J Agric Food Chem
Sesamol Epigenetically Induces Estrogen Receptor α Re-expression by Upregulating miR-370-3p in Estrogen Receptor α-Negative Breast Cancer. [Abstract]2021 Aug 11;69(31):8737-8746. PMID: 34325508 -
Biochem Pharmacol
S-adenosylmethionine attenuates angiotensin II-induced aortic dissection formation by inhibiting vascular smooth muscle cell phenotypic switch and autophagy. [Abstract]2024 Jan:219:115967. PMID: 38065291 -
-
Plant J
Transcriptomic and metabolomic analyses unveil TaASMT3-mediated wheat resistance against stripe rust by promoting melatonin biosynthesis. [Abstract]2025 Apr;122(2):e70182. PMID: 40298361 -
Int Immunopharmacol
Hydrogen sulfide ameliorates high glucose-induced pro-inflammation factors in HT-22 cells: Involvement of SIRT1-mTOR/NF-κB signaling pathway. [Abstract]2021 Jun:95:107545. PMID: 33765609
S-Adenosyl-L-methionine 1,4-butanedisulfonate purchased from MedChemExpress. Usage Cited in: Int Immunopharmacol. 2021 Jun:95:107545. [Abstract]
S-adenosylmethionine (SAMe) application at 30 min prior to high glucose treatment significantly increased H2S levels compared with the HG group. The cystathionine-β-synthase (CBS) level is obviously elevated in HG + SAMe group compared with the HG group.
-
Epigenetics Chromatin
Ethionine-mediated reduction of S-adenosylmethionine is responsible for the neural tube defects in the developing mouse embryo-mediated m6A modification and is involved in neural tube defects via modulating Wnt/β-catenin signaling pathway. [Abstract]2021 Dec 4;14(1):52. PMID: 34863249 -
J Pharm Biomed Anal
Quantitative determination of ademetionine in tablets utilizing ATR-FTIR and partial least squares methods approaches. [Abstract]2024 Apr 15:241:115991. PMID: 38301577 -
-
Biomed Pharmacother
Identification of nsp16 inhibitors of SARS -CoV-2, SARS -CoV-1 and MERS-CoV from FDA-approved drugs using in silico and in vitro methods. [Abstract]2025 Aug:189:118246. PMID: 40543162 -
-
-
-
Purity & Documentation
References
[1]. G M Bressa. S-adenosyl-l-methionine (SAMe) as antidepressant: meta-analysis of clinical studies. Acta Neurol Scand Suppl. 1994;154:7-14. [Content Brief]
[2]. Wadie I Najm, et al. S-adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: a double-blind cross-over trial. [ISRCTN36233495]. BMC Musculoskelet Disord. 2004 Feb 26;5:6. [Content Brief]
[3]. Shelly C Lu, et al. S-adenosylmethionine in liver health, injury, and cancer. Physiol Rev. 2012 Oct;92(4):1515-42. [Content Brief]
[4]. Mosca L, et al. Effects of S‑adenosyl‑L‑methionine on the invasion and migration of head and neck squamous cancer cells and analysis of the underlying mechanisms. Int J Oncol. 2020 May;56(5):1212-1224. [Content Brief]
[5]. Ham MS, et al. S-adenosyl methionine specifically protects the anticancer effect of 5-FU via DNMTs expression in human A549 lung cancer cells. Mol Clin Oncol. 2013 Mar;1(2):373-378. [Content Brief]
[6]. Ornoy A, et al. S-adenosyl methionine prevents ASD like behaviors triggered by early postnatal valproic acid exposure in very young mice. Neurotoxicol Teratol. 2019 Jan-Feb;71:64-74. [Content Brief]
[7]. Dhediya RM, et al. Evaluation of antiepileptic effect of S-adenosyl methionine and its role in memory impairment in pentylenetetrazole-induced kindling model in rats. Epilepsy Behav. 2016 Aug;61:153-157. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)